PRA_StandardLogo_RGB_Pink.png
PRA’s Center for Rare Diseases Launches Toolkit to Identify and Mitigate Risks to Rare Disease Clinical Programs
March 22, 2021 16:01 ET | PRA Health Sciences, Inc.
RALEIGH, N.C., March 22, 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ: PRAH) announced today the launch of its Patient-Centric Trial Development Toolkit, available now to clinical...
PRA_StandardLogo_RGB_Pink.png
PRA Health Sciences, Inc. Reports Fourth Quarter and Full Year 2020 Results
February 24, 2021 06:04 ET | PRA Health Sciences, Inc.
Net new business of $872.4 million in the fourth quarter excluding reimbursement revenue; representing growth of 32.4%; Net book-to-bill of 1.42Net new business of $1,437.8 million in the fourth...
PRA_StandardLogo_RGB_Pink.png
PRA Health Sciences to Report Fourth Quarter and Full Year 2020 Earnings
February 04, 2021 13:01 ET | PRA Health Sciences, Inc.
RALEIGH, N.C., Feb. 04, 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) will release its fourth quarter and full year 2020 results after the market closes on Thursday, February 25,...
PRA_StandardLogo_RGB_Pink.png
PRA Health Sciences collaborates with PWNHealth and Fulgent Genetics to provide at-home COVID-19 test capabilities
December 17, 2020 16:02 ET | PRA Health Sciences, Inc.
RALEIGH, N.C., Dec. 17, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ: PRAH) announced today the enhancement of its COVID-19 Monitoring Program with the addition of at-home COVID-19 testing...
PRA_StandardLogo_RGB_Pink.png
PRA Health Sciences任命FDA高级官员领导新的去中心化临床试验战略全球卓越中心
November 23, 2020 14:28 ET | PRA Health Sciences, Inc.
北卡罗来纳州罗利市, Nov. 24, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc.(NASDAQ:PRAH)今天宣布任命Isaac...
PRA_StandardLogo_RGB_Pink.png
PRA Health Sciences nomeia alto funcionário da FDA para liderar o novo Centro Global de Excelência da Estratégia de Testes Clínicos Descentralizados
November 23, 2020 14:28 ET | PRA Health Sciences, Inc.
RALEIGH, N.C., Nov. 23, 2020 (GLOBE NEWSWIRE) -- A PRA Health Sciences, Inc. (NASDAQ: PRAH) anunciou hoje a nomeação de Isaac Rodriguez-Chávez, PhD, MHS, MS, como Vice-Presidente Sênior, Assuntos...
PRA_StandardLogo_RGB_Pink.png
PRA Health Sciences melantik pegawai kanan FDA untuk mengetuai Pusat Kecemerlangan Global untuk Strategi Kajian Klinikal Terpencar
November 23, 2020 14:28 ET | PRA Health Sciences, Inc.
RALEIGH, N.C., Nov. 24, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) hari ini mengumumkan pelantikan Isaac Rodriguez-Chavez, PhD, MHS, MS sebagai Timbalan Presiden Kanan, Hal...
PRA_StandardLogo_RGB_Pink.png
PRAヘルスサイエンス、FDAシニアオフィサーを分散型臨床試験戦略のグローバル・センター・オブ・エクセレンス統括者に任命
November 23, 2020 14:28 ET | PRA Health Sciences, Inc.
ノースカロライナ州ローリー発, Nov. 24, 2020 (GLOBE NEWSWIRE) -- PRAヘルスサイエンス (PRA Health Sciences, Inc.、NASDAQ: PRAH) は本日、アイザック・ロドリゲス・チャベス (Isaac Rodriguez-Chavez) 博士 (保健学修士、理学修士)...
PRA_StandardLogo_RGB_Pink.png
PRA Health Sciences nomme un haut responsable de la FDA pour diriger le nouveau Centre mondial d'excellence pour la stratégie d'essais cliniques décentralisés
November 23, 2020 14:28 ET | PRA Health Sciences, Inc.
RALEIGH, Caroline du Nord, 23 nov. 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ : PRAH) a annoncé aujourd'hui la nomination d'Isaac Rodriguez-Chavez, PhD, MHS, MME, au poste de...
PRA_StandardLogo_RGB_Pink.png
PRA Health Sciences 任命高級 FDA 官員領導新全球分散式臨床試驗策略卓越中心
November 23, 2020 14:28 ET | PRA Health Sciences, Inc.
北卡羅萊納州拉里格, Nov. 24, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) 今天宣佈任命 Isaac Rodriguez-Chavez 博士、環境健康科學碩士兼理學碩士為科學和臨床事務高級副總裁。他將領導公司的全球分散式臨床試驗策略卓越中心。Rodriguez-Chavez 博士的職責包括實現...